Globus Medical Inc - Class A

NYSE: GMED
$52.47
-$0.64 (-1.2%)
Closing price April 11, 2024
Globus Medical Inc is a leading innovator in the medical device industry, focusing on developing solutions for musculoskeletal disorders. With a broad portfolio, the company offers spine products, motion preservation technologies, and interventional solutions for vertebral fractures. Additionally, it provides orthopedic trauma care products and joint solutions for hips and knees. Globus Medical stands out for its commitment to improving patient care through advanced technology, including regenerative biologic products. Founded in 2003 and based in Audubon, Pennsylvania, it markets its products globally through a mix of direct sales and distributors.
Wednesday's top analyst upgrades and downgrades included Arm, Carnival, CVS Health, Deere, Dell Technologies, Intercontinental Exchange, Planet Fitness, Rackspace Technology, Royal Caribbean Cruises,...
Tuesday's top analyst upgrades and downgrades included Agilon Health, Boston Scientific, General Motors, JPMorgan Chase, Match, Moderna, Okta, Palo Alto Networks, Snap, Uber Technologies and Wells...
Friday's top analyst upgrades and downgrades included American Tower, Charles Schwab, Crown Castle, DiamondRock Hospitality, DraftKings, Enphase Energy, GitLab, Interpublic Group of Companies,...
Monday's top analyst upgrades and downgrades included AbbVie, Affirm, Bloom Energy, FREYR Battery, International Flavors & Fragrances, Interpublic Group of Companies, Lyft, Micron Technology,...
Monday's top analyst upgrades and downgrades included Advanced Micro Devices, Danaher, DoorDash, Freeport-McMoRan, Gap, Gilead Sciences, Huntington Bancshares, Independence Realty Trust, Intuitive...
Tuesday's top analyst upgrades and downgrades included Apple, Beyond Meat, Chesapeake Energy, Chewy, CrowdStrike, DraftKings, Qualtrics International, SAP, Sono, Tata Motors and Unity Software.
Credit Suisse has assembled its favorite health care recovery stocks for a recovering base of elective surgeries and for the risk of rising hospitalizations that go well beyond COVID-19.
It's another day that the markets are open, so it is widely assumed that Warren Buffett and his Berkshire Hathaway are out looking for deals to make.
A Credit Suisse analyst issued a broad new sector coverage for medical devices and related companies with strong Outperform ratings on Tuesday.
The top analyst upgrades, downgrades and initiations seen on Tuesday included Abbott Laboratories, Albermarle, Boston Scientific, BP, Embraer, Intuit, Marathon Oil and Norfolk Southern.
The top analyst upgrades, downgrades and other research calls from Friday include AMD, CVS Health, Disney, Fiat Chrysler, Kinross Gold, Kohl's and NVIDIA.
Source: Thinkstock24/7 Wall St. has tracked nine key stocks on the move in the after-hours trading session on Tuesday, August 5, 2014. There will have been other movers as well, but these were the...
Here are four top medical device makers that the Leerink team thinks make sense as potential takeover candidates, but also have more than enough merit to stand on their own.
At this time last year, the sentiment on Wall Street for the medtech sector was very poor. The bearish sentiment that prevailed in January of 2013 is gone, but expectations are still tempered. That...
Facebook Inc. (NASDAQ: FB), Groupon Inc. (NASDAQ: GRPN), and Zynga, Inc. (NASDAQ: ZNGA) have all been duds for the market around initial public offerings. These three IPOs have destroyed billions of...